Literature DB >> 15134348

Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS.

Markus G Donner1, Ulrich Warskulat, Nirmalendu Saha, Dieter Häussinger.   

Abstract

Lipopolysaccharide (LPS) induces hepatocellular down-regulation and endocytic retrieval of multidrug resistance protein 2 (Mrp2, Abcc2). Basolateral Mrp isoforms may compensate for the intracellular metabolic changes in cholestasis. Therefore, the effect of LPS on the zonal localization of Mrp2 and Mrp3 and the expression of Mrp3, Mrp4, Mrp5, and Mrp6 mRNA were investigated in rat liver. In normal rat liver Mrp3 was found in pericentral hepatocytes also expressing glutamine synthetase. In LPS-treated rat liver the decrease in Mrp2 protein was most pronounced in pericentral hepatocytes, with only minor down-regulation in periportal hepatocytes. Conversely, induction of Mrp3 was found in pericentral hepatocytes with a low expression of Mrp2. Furthermore, we found a strong induction of Mrp5 mRNA. Likewise, Mrp6 mRNA was up-regulated, however Mrp6 protein expression was not significantly altered. It is concluded that Mrp3 is inversely regulated to Mrp2 in a zonal pattern and may compensate for the LPS-induced loss of Mrp2 in the perivenous area. Induction of pericentral Mrp3 and up-regulation of Mrp5 mRNA may play an important role in the hepatocellular clearance of cholephilic substances and cyclic nucleotides accumulating after LPS treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134348     DOI: 10.1515/BC.2004.029

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  12 in total

Review 1.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

Authors:  K Sandy Pang; Michael Weiss; Panos Macheras
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

Review 2.  Cholestatic liver (dys)function during sepsis and other critical illnesses.

Authors:  Marc Jenniskens; Lies Langouche; Yoo-Mee Vanwijngaerden; Dieter Mesotten; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2015-09-21       Impact factor: 17.440

3.  Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway.

Authors:  Jin Chai; Yu He; Shi-Ying Cai; Zhongyong Jiang; Huaizhi Wang; Qiong Li; Lei Chen; Zhihong Peng; Xiaochong He; Xiaoping Wu; Tianli Xiao; Rongquan Wang; James L Boyer; Wensheng Chen
Journal:  Hepatology       Date:  2012-05       Impact factor: 17.425

Review 4.  The role of inflammation in cholestasis: clinical and basic aspects.

Authors:  Astrid Kosters; Saul J Karpen
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

Review 5.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

Review 6.  Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases.

Authors:  M Arrese; S J Karpen
Journal:  Clin Pharmacol Ther       Date:  2010-03-03       Impact factor: 6.875

7.  Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid.

Authors:  Jonathan M Maher; Lauren M Aleksunes; Matthew Z Dieter; Yuji Tanaka; Jeffrey M Peters; Jose E Manautou; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2008-08-29       Impact factor: 4.849

Review 8.  Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis.

Authors:  Jaap Mulder; Saul J Karpen; Uwe J F Tietge; Folkert Kuipers
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

9.  Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis.

Authors:  Peter Recknagel; Falk A Gonnert; Martin Westermann; Sandro Lambeck; Amelie Lupp; Alain Rudiger; Alex Dyson; Jane E Carré; Andreas Kortgen; Christoph Krafft; Jürgen Popp; Christoph Sponholz; Valentin Fuhrmann; Ingrid Hilger; Ralf A Claus; Niels C Riedemann; Reinhard Wetzker; Mervyn Singer; Michael Trauner; Michael Bauer
Journal:  PLoS Med       Date:  2012-11-13       Impact factor: 11.069

10.  The importance of transporters and cell polarization for the evaluation of human stem cell-derived hepatic cells.

Authors:  György Török; Zsuzsa Erdei; Julianna Lilienberg; Ágota Apáti; László Homolya
Journal:  PLoS One       Date:  2020-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.